Cargando…
Burning and Scaling Probably Associated with Dupilumab Therapy: A Case Report
CASE REPORT: We present the case of a 51-year-old male who experienced temporary desquamation and recurrent burning sensation in primary skin lesions after the injection of dupilumab. The scaling lasted for 1 week and subsided, while the burning became aggravated with each injection of dupilumab, wh...
Autores principales: | Luo, Nana, Wang, Qiuyue, Lei, Min, Li, Zhiyong, Li, Tianhao, Hao, Pingsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393013/ https://www.ncbi.nlm.nih.gov/pubmed/36000004 http://dx.doi.org/10.2147/CCID.S373997 |
Ejemplares similares
-
Dupilumab for Chronic Prurigo in Different Backgrounds: A Case Series
por: Luo, Nana, et al.
Publicado: (2022) -
Tofacitinib for the Treatment of Psoriasiform Dermatitis Caused by IL-17 Inhibitors: A Case Report
por: Luo, Nan, et al.
Publicado: (2023) -
Bullous Grover’s Disease in a Chinese Tibetan Adolescent: A Case Report
por: Wang, Qiuyue, et al.
Publicado: (2022) -
Tofacitinib for Prurigo Nodularis: A Case Report
por: Peng, Changlan, et al.
Publicado: (2022) -
Successful Treatment of Recurrent Adult-Onset Still’s Disease with Tocilizumab: A Case Report and Literature Review
por: Zhong, Xiaojing, et al.
Publicado: (2023)